Guide to the quality and safety of organs for transplantation
Transplant medicine and transplantation have progressed during the last decades in a way that nobody would have imagined before. The transplantation of organs offers major therapeutic benefits and improvements to quality of life and is, in many cases, the only life-saving treatment for end-stage organ failure.
This new 6th Edition of the Guide collates updated information to provide professionals identifying organ donors, transplant co-ordinators managing the donation process and transplant physicians responsible for organ allocation and utilisation with a useful overview of the most recent advancements in the field.
It is intended to provide easy-to-use information and guidance to all professionals involved in donation and transplantation of organs so as to maximise their quality and to minimise risks and, thereby, improve the success rate of transplants.
Guide to the quality and safety of tissues and cells for human application
Human tissues and cells are being used in an increasing variety of ways, and advances in transplantation therapy have unquestionable benefits. Human cells and tissues for human application can save lives or restore essential functions, but the use of human tissues and cells also raises questions of safety and quality.
This 3rd Edition of the Guide to the quality and safety of tissues and cells for human application contains information and guidance for all professionals involved in identifying potential donors, transplant co-ordinators managing the process of donation after death, bone marrow and cord blood collection centres, fertility clinics, tissue establishments processing and storing tissues and cells, testing laboratories, organisations responsible for human application, inspectors auditing the establishments, and Health Authorities responsible for tissues and cells for human application.
The Guide is divided into three parts. Part A (Chapters 1-15) contains general requirements applicable to all tissue establishments and organisations involved in the donation, procurement, testing, processing, preservation, storage and distribution of tissues and cells. Part B (Chapters 16-25) contains specific guidelines and requirements for the various tissue and cell types. The new Part C (Chapters 26-29) of this guide introduces novel therapeutic approaches, most of them under development, such as cell-based therapies, decellularisation techniques and the use of natural scaffolds for clinical application, or the human application of other human-derived substances such as breast milk, faecal microbiota, platelet-rich plasma or serum eye drops. This section includes not only tissues and cells that are already in routine use in patients but others that are in research and development and are currently undergoing clinical trials.